glp-1 breast cancer recurrence Receptor Agonists in Cancer: A New Frontier in Obesity and Prognosis Management GLP-1 may improve survival, reduce

Reduced food intake is common during weight loss

The Australian and New Zealand College of Anaesthetists (ANZCA), the Gastroenterological Society of Australia, the Australian Diabetes Society, and the National Association of Clinical Obesity Services and Australian and New Zealand Metabolic and the Obesity Surgery Society have developed revised recommendations for patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation

Theres a black box warning against use in people with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2

Lofton suggests that nutrition guidance be tailored to a patients likes, dislikes, and lifestyle

doi: 10.1111/tbj.2009.16.issue-1 20 PetrekJASenieRTPetersMRosenPP